Nemaura Medical Inc NMRD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 09/24/21 EDT
6.10quote price arrow up+0.11 (+1.84%)
Volume
35,666
52 week range
3.12 - 17.40
Loading...
  • Open5.90
  • Day High6.13
  • Day Low5.70
  • Prev Close5.99
  • 52 Week High17.40
  • 52 Week High Date06/01/21
  • 52 Week Low3.12
  • 52 Week Low Date09/25/20

Key Stats

  • Market Cap142.19M
  • Shares Out23.31M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-0.36
  • YTD % Change61.8

KEY STATS

  • Open5.90
  • Day High6.13
  • Day Low5.70
  • Prev Close5.99
  • 52 Week High17.40
  • 52 Week High Date06/01/21
  • 52 Week Low3.12
  • 52 Week Low Date09/25/20
  • Market Cap142.19M
  • Shares Out23.31M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-0.36
  • YTD % Change61.8

RATIOS/PROFITABILITY

  • EPS (TTM)-0.37
  • P/E (TTM)-16.43
  • Fwd P/E (NTM)-13.86
  • EBITDA (MRQ)-5.182M
  • ROE (MRQ)-171.28%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)315.89%

EVENTS

  • Earnings Date11/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nemaura Medical Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nemaura Medical, Inc. is a holding company. The Company, through its subsidiaries, performs medical device research and manufacturing of a continuous glucose monitoring system (CGM), named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients. SugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays...
Dewan Chowdhury Ph.D.
Chairman
Justin Mclarney
Chief Financial Officer
Address
57 W 57th St
New York, NY
10019-2802
United States